| RS1135401891 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401892 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401893 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401894 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401896 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401897 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast and/or ovarian cancer |
| RS1135401898 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1135401899 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401900 |
BRCA2
|
Health Risk |
Pathogenic |
BRCA2-related disorder, Breast-ovarian cancer |
| RS1135401901 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401902 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401903 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1135401904 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401905 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401906 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401907 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401908 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401910 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401912 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401914 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401915 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401916 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401917 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1135401918 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1135401919 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401921 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401922 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401923 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401924 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401925 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401927 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401928 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Malignant tumor of breast |
| RS1135401929 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401932 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401933 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401935 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401936 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401937 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401938 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401944 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1135401950 |
KCNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS1135401953 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta |
| RS1135401954 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS1135401955 |
KCNQ5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS1135401956 |
KCNQ5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS1135401957 |
KCNQ5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS1135401958 |
KCNQ5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS1135401959 |
DONSON
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS1135401960 |
DONSON
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, short stature |
| RS1135401961 |
DONSON
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS1135402725 |
PDHX
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS1135402732 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1135402736 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, Vici syndrome |
| RS1135402737 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402738 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402739 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402741 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402742 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402743 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402744 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402745 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1135402746 |
P4HA2
|
Health Risk |
Pathogenic |
Myopia 25, autosomal dominant |
| RS1135402748 |
PLS3
|
Health Risk |
Pathogenic |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS1135402749 |
NDUFV1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS1135402750 |
BAG3
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1HH, Dilated cardiomyopathy 1HH |
| RS1135402752 |
MAMLD1
|
Health Risk |
Pathogenic |
Hypospadias 2, X-linked |
| RS1135402754 |
DZIP1L
|
Health Risk |
Pathogenic |
Polycystic kidney disease 5, Polycystic kidney disease 5 |
| RS1135402755 |
DZIP1L
|
Health Risk |
Pathogenic |
Polycystic kidney disease 5, Polycystic kidney disease 5 |
| RS1135402756 |
DZIP1L
|
Health Risk |
Pathogenic |
Polycystic kidney disease 5, Polycystic kidney disease 5 |
| RS1135402758 |
NUP214
|
Health Risk |
Likely pathogenic |
Congenital anomaly of face, Growth delay |
| RS1135402759 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1135402760 |
BRSK2
|
Health Risk |
Likely pathogenic |
— |
| RS1135402761 |
SYT1
|
Health Risk |
Pathogenic/Likely pathogenic |
SYT1-associated neurodevelopmental disorder, Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome |
| RS1135402762 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402764 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402765 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402766 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402767 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1135402768 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402769 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402773 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1135402774 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402776 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402777 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402778 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402779 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402780 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1135402783 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1135402784 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402785 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1135402787 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1135402788 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402789 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402790 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1135402791 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402792 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402793 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402794 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1135402795 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1135402796 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |